Viridian Therapeutics, Inc. (VRDN)
24.18
+0.16
(+0.67%)
USD |
NASDAQ |
Aug 25, 16:00
24.18
0.00 (0.00%)
After-Hours: 16:17
Viridian Therapeutics Debt to Equity Ratio : 0.3668 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.3668 |
| March 31, 2026 | 0.0805 |
| December 31, 2025 | 0.0702 |
| September 30, 2025 | 0.0474 |
| June 30, 2025 | 0.0447 |
| March 31, 2025 | 0.0382 |
| December 31, 2024 | 0.0344 |
| September 30, 2024 | 0.0329 |
| June 30, 2024 | 0.0426 |
| March 31, 2024 | 0.0377 |
| December 31, 2023 | 0.0499 |
| September 30, 2023 | 0.0777 |
| June 30, 2023 | 0.0219 |
| March 31, 2023 | 0.0179 |
| December 31, 2022 | 0.0161 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.043 |
| March 31, 2022 | 0.0098 |
| December 31, 2021 | 0.0055 |
| September 30, 2021 | 0.0132 |
| June 30, 2021 | 0.016 |
| March 31, 2021 | 0.0033 |
| December 31, 2020 | 0.0041 |
| September 30, 2020 | 0.4391 |
| June 30, 2020 | 0.4343 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2841 |
| December 31, 2019 | 0.5271 |
| September 30, 2019 | 0.3984 |
| June 30, 2019 | 0.3036 |
| March 31, 2019 | 0.2537 |
| December 31, 2018 | 0.2006 |
| September 30, 2018 | 0.1681 |
| June 30, 2018 | 0.1494 |
| March 31, 2018 | 0.1378 |
| December 31, 2017 | 0.2576 |
| September 30, 2017 | 0.0865 |
| June 30, 2017 | 0.0931 |
| March 31, 2017 | 0.09 |
| December 31, 2016 | 0.3181 |
| September 30, 2016 | 0.2358 |
| June 30, 2016 | 0.1717 |
| March 31, 2016 | 0.1325 |
| December 31, 2015 | 0.1061 |
| September 30, 2015 | 0.0875 |
| June 30, 2015 | 0.101 |
| March 31, 2015 | 0.0805 |
| December 31, 2014 | 0.1878 |
| September 30, 2014 | 0.0014 |
| June 30, 2014 | 0.0013 |
| December 31, 2013 | -1.114 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
| Anika Therapeutics, Inc. | 0.1839 |
| Savara, Inc. | 0.2117 |
| Vericel Corp. | 0.2556 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.097B |
| Total Liabilities (Quarterly) | 435.14M |
| Shareholders Equity (Quarterly) | 662.10M |
| Current Ratio | 16.95 |
| Net Debt Paydown Yield | -2.11% |